Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting

8 Aug 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40781362
DOI: 10.1007/s12035-025-05264-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic TargetingPMID 40781362Read ↗

Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?Semantic proximity Read ↗

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agentsSemantic proximity Read ↗

Histone Deacetylase Inhibition in Alzheimer’s Disease: Molecular Mechanisms, Therapeutic Potential, and Future PerspectivesSemantic proximity Read ↗

HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological DisordersSemantic proximity Read ↗

Defining molecular targets to prevent Alzheimer disease.Semantic proximity Read ↗

Targeting epigenetics: A novel promise for Alzheimer’s disease treatmentSemantic proximity Read ↗

Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated PathwaysSemantic proximity Read ↗

Alzheimer’s disease pathogenesis and therapeutic interventionsSemantic proximity Read ↗

Molecular targets of histone deacetylase inhibitors in neurodegeneration and neuroprotectionSemantic proximity Read ↗

SIRT2 as a potential new therapeutic target for Alzheimer’s diseaseSemantic proximity Read ↗

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategiesSemantic proximity Read ↗

Histone Modifications in Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.